Knowledge Mapping and Frontier Evolution of Traditional Medicine in Hepatocellular Carcinoma Research: A Bibliometric Analysis.

IF 3.9 3区 医学 Q2 ONCOLOGY
Journal of Hepatocellular Carcinoma Pub Date : 2026-10-12 eCollection Date: 2026-01-01 DOI:10.2147/JHC.S624162
Ling Cai, Gang Wang, Tao Yang, Honglin Luo
{"title":"Knowledge Mapping and Frontier Evolution of Traditional Medicine in Hepatocellular Carcinoma Research: A Bibliometric Analysis.","authors":"Ling Cai, Gang Wang, Tao Yang, Honglin Luo","doi":"10.2147/JHC.S624162","DOIUrl":null,"url":null,"abstract":"<p><p>Hepatocellular carcinoma (HCC) is a common malignancy worldwide. Existing treatments are limited by high recurrence rates and drug resistance. Traditional medicine have the potential to be used to treat HCC because of their multi-target and low toxicity properties, however, there is no general review of the state of studies and tendencies. According to Web of Science Core Collection (WoSCC), this paper has analyzed 1936 English articles and reviews through bibliometric analysis of the data with CiteSpace and Bibliometrix, including publication trends, country/region distribution, the occurrence of keywords, collaboration networks, thematic evolution. The output of literature has been growing exponentially since 2020. The main contributor is China, which plays a central role in international cooperation. An important partner is the United States, and Egypt and France are possible partners. The area of interest is active ingredients, apoptosis modulation, and networking pharmacology. Network pharmacology and molecular docking are fundamental technologies. Emerging frontiers are tumor microenvironment, gut microbiota, lipid metabolism, and NF-κB signaling pathway. NF-κB activation, apoptosis, and angiogenesis regulation are new hotspots. This study systematically elucidates the research status and future directions of traditional medicine in the treatment of HCC, providing a reference for the prevention and treatment of HCC with traditional medicine. However, this study exclusively selected the WoSCC database for analysis, which may have the limitation of not comprehensively covering all research achievements relevant to this field.</p>","PeriodicalId":15906,"journal":{"name":"Journal of Hepatocellular Carcinoma","volume":"13 ","pages":"624162"},"PeriodicalIF":3.9000,"publicationDate":"2026-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13674563/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Hepatocellular Carcinoma","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/JHC.S624162","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Hepatocellular carcinoma (HCC) is a common malignancy worldwide. Existing treatments are limited by high recurrence rates and drug resistance. Traditional medicine have the potential to be used to treat HCC because of their multi-target and low toxicity properties, however, there is no general review of the state of studies and tendencies. According to Web of Science Core Collection (WoSCC), this paper has analyzed 1936 English articles and reviews through bibliometric analysis of the data with CiteSpace and Bibliometrix, including publication trends, country/region distribution, the occurrence of keywords, collaboration networks, thematic evolution. The output of literature has been growing exponentially since 2020. The main contributor is China, which plays a central role in international cooperation. An important partner is the United States, and Egypt and France are possible partners. The area of interest is active ingredients, apoptosis modulation, and networking pharmacology. Network pharmacology and molecular docking are fundamental technologies. Emerging frontiers are tumor microenvironment, gut microbiota, lipid metabolism, and NF-κB signaling pathway. NF-κB activation, apoptosis, and angiogenesis regulation are new hotspots. This study systematically elucidates the research status and future directions of traditional medicine in the treatment of HCC, providing a reference for the prevention and treatment of HCC with traditional medicine. However, this study exclusively selected the WoSCC database for analysis, which may have the limitation of not comprehensively covering all research achievements relevant to this field.

传统医学在肝细胞癌研究中的知识图谱和前沿发展:文献计量学分析。
肝细胞癌(HCC)是世界范围内常见的恶性肿瘤。现有的治疗方法受到高复发率和耐药性的限制。传统医学由于其多靶点和低毒性的特点,具有治疗HCC的潜力,然而,目前还没有对其研究现状和趋势进行全面的回顾。本文以Web of Science Core Collection (WoSCC)为基础,利用CiteSpace和Bibliometrix对1936篇英文论文和综述进行文献计量分析,包括发表趋势、国家/地区分布、关键词出现、合作网络、专题演变等。自2020年以来,文学产出呈指数级增长。主要贡献者是在国际合作中发挥核心作用的中国。一个重要的合作伙伴是美国,埃及和法国是可能的合作伙伴。感兴趣的领域是活性成分,细胞凋亡调节和网络药理学。网络药理学和分子对接是基础技术。肿瘤微环境、肠道菌群、脂质代谢和NF-κB信号通路是新兴的研究前沿。NF-κB活化、细胞凋亡和血管生成调控是新的研究热点。本研究系统阐述了传统医学在HCC治疗中的研究现状及未来发展方向,为传统医学防治HCC提供参考。但是,本研究只选择了WoSCC数据库进行分析,可能存在不能全面覆盖该领域所有相关研究成果的局限性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
0.50
自引率
2.40%
发文量
108
审稿时长
16 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书